Mitochondrial oxygen use in blood, muscle, and skin of people with long COVID
Official title: Mitochondrial Oxygen Consumption and Substrate Utilisation In Vitro in Peripheral Blood Mononuclear Cells, and In Vivo on Muscle and Skin in Long COVID Patients and Convalescent Individuals: A Case-Control and Diagnostic Accuracy Study
Run by Universitair Ziekenhuis Brussel · NCT07134673 · Data updated 2026-11-12
Researchers will test whether mitochondria use oxygen differently in blood cells, muscle, and skin of people with long COVID compared with people who fully recovered after COVID-19.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 54 (estimated) |
| Sponsor | Universitair Ziekenhuis Brussel Academic / other |
| Locations | 1 site (Jette, Brussels Capital) |
| Status | Recruiting |
| Started | January 21, 2026 |
| Main results expected | July 2026 |
| Study ends | July 2026 |
| Registry record updated | April 22, 2026 |
| Trial ID | NCT07134673 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (≥18) with a confirmed past SARS-CoV-2 infection who meet the WHO definition of long COVID with symptoms for at least six months and a Post-COVID-19 Functional Status grade 2–4 (pre-infection grade 0).
✕Probably not a fit
People with pre-existing chronic diseases that affect functional status, those taking metabolism-altering drugs, individuals with high alcohol intake, or those with skin conditions aggravated by sunlight or who cannot understand Dutch, French, or English may not be eligible or likely to directly benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will compare mitochondrial oxygen consumption between adults with long COVID (symptoms ≥6 months) and convalescent individuals who fully recovered, using three measurement techniques applied to peripheral blood mononuclear cells, skeletal muscle, and skin. Participants will complete surveys, wear an activity tracker for seven days, undergo non-invasive functional tests across two visits about a week apart, and provide a blood sample. The protocol also examines how well the three techniques agree in quantifying oxygen use across the three tissues. Results will look for consistent differences that could indicate mitochondrial dysfunction in long COVID.
Why it matters
Potential benefit: If successful, the study could identify measurable mitochondrial changes that help diagnose long COVID or guide future targeted treatments.
How similar studies have gone: Small prior studies and research in related conditions like ME/CFS have suggested mitochondrial abnormalities, but findings are limited and inconsistent, so this specific multi-tissue comparison is partly supported but remains novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Individuals with long COVID: Inclusion criteria: * Long COVID diagnosis, based on the WHO definition; * Presence of long COVID symptoms for a minimum of 6 months. * History of confirmed or documented SARS-CoV-2 infection. * Adult (≥18 years of age). * Post-COVID-19 Functional Status Scale grade 2-4, while they had a grade 0 before the SARS-CoV-2 infection. Exclusion criteria: * Pre-existing chronic diseases potentially affecting the functional status scale. * Treatment with metabolism altering drugs. * \> 10 standard units of alcohol (10 grams of alcohol/glass) per week. * Unable to understand oral and written instructions in Dutch, French or English. * Allergies to medical adhesive bandages. * Porphyria and other skin conditions aggravated by sunlight. Convalescent individuals Inclusion criteria: * History of confirmed or documented SARS-CoV-2 infection. * Complete recovery after the SARS-CoV-2 infection, no history of long COVID based on the WHO definition; * Post-COVID-19 Functional Status Scale \[2\] grade 0 both before the infection and currently. * Adult (≥18 years of age). Exclusion criteria: * Pre-existing chronic non-communicable diseases (e.g. hypertension, chronic respiratory diseases, diabetes). * Treatment with metabolism altering drugs. * \> 10 standard units of alcohol (10 grams of alcohol/glass) per week. * Unable to understand oral and written instructions in Dutch, French or English. * Allergies to medical adhesive bandages. * Porphyria and other skin conditions aggravated by sunlight.
Where it's running
-
Laarbeeklaan 101
Jette, Brussels Capital, Belgium Recruiting
Study contacts
- Principal investigator: Elisabeth De Waele, MD. PhD. — Vitality Research Group, Metabolism and Nutrition, Vrije Universiteit Brussel (VUB), Clinical Nutrition Department, Universitair Ziekenhuis Brussel (UZ Brussel)
- Study coordinator: Berenice G. Jimenez Garcia, Master of Science
- Email: berenice.gabriela.jimenez.garcia@vub.be
- Phone: +3224749624
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hi-OxSR to treat post-COVID cognitive problems
This trial will test whether using the Hi-OxSR breathing device can help adults with long COVID who have ongoing cognitive problems and fatigue.
-
Hyperbaric oxygen therapy for Long COVID cognitive symptoms
This study will test whether hyperbaric oxygen therapy can improve lingering cognitive symptoms like brain fog and memory problems in adults who had COVID-19.
-
Rehabilitation program to reduce fatigue after COVID-19
This study is testing a new rehabilitation program called COVIDEx to see if it can help people with Long COVID feel less tired compared to standard care.
-
Transcranial Direct Current Stimulation for Long COVID with Headaches and Chronic Pain
This study tests whether applying mild brain stimulation (tDCS) can help people with long COVID who have headaches, migraines, and ongoing pain.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
-
Fatigue Investigation Using Digital Outcomes
This study tests whether digital monitoring with a smartphone app and wearables can track fatigue in people with MS or long COVID, compared with healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.